The role of immune dysfunction in the pathophysiology of autism

Brain, Behavior, and Immunity

Volumn 26, Issue 3, 2012, Pages 383-392

  Onore, Charity ^a,b   Careaga, Milo ^a,b   Ashwood, Paul ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Cytokines; Maternal immune activation; Monocytes; Social interactions; T cells

Indexed keywords

AUTOANTIBODY; CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ASTROCYTE; AUTISM; B LYMPHOCYTE; BEHAVIOR; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL FUNCTION; CELL MATURATION; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CEREBROSPINAL FLUID LEVEL; COGNITION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; DISEASE ASSOCIATION; ENCEPHALITIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INNATE IMMUNITY; INTERPERSONAL COMMUNICATION; MACROPHAGE; MICROGLIA; MONOCYTE; NATURAL KILLER CELL; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SOCIAL INTERACTION; SYNAPSE; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; AUTISTIC DISORDER; BRAIN; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 84857190395     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.08.007     Document Type: Review

References (134)

1. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 2008, 9:341-355.
2. Diagnostic and Statistical Manual of Mental Disorders 2000, APA, American Psychiatric Publishing, Inc., Arlington, VA.
3. Ashwood P., Wakefield A.J. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 2006, 173:126-134.
4. Ashwood P., Anthony A., Torrente F., Wakefield A.J. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol. 2004, 24:664-673.
5. Ashwood P., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R.L., Croen L.A., Ozonoff S., Pessah I.N., Van de Water J. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J. Neuroimmunol. 2008, 204:149-153.
6. Ashwood P., Corbett B.A., Kantor A., Schulman H., Van de Water J., Amaral D.G. In search of cellular immunophenotypes in the blood of children with autism. PLoS One 2011, 6:e19299.
7. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25:40-45.
8. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Altered T cell responses in children with autism. Brain Behav. Immun. 2010, 25(5):840-849.
9. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J. Neuroimmunol. 2011, 232:196-199.
10. Atladottir H.O., Pedersen M.G., Thorsen P., Mortensen P.B., Deleuran B., Eaton W.W., Parner E.T. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009, 124:687-694.
11. Atladottir H.O., Thorsen P., Ostergaard L., Schendel D.E., Lemcke S., Abdallah M., Parner E.T. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 2010, 40:1423-1430.
12. Baier P.C., May U., Scheller J., Rose-John S., Schiffelholz T. Impaired hippocampus-dependent and -independent learning in IL-6 deficient mice. Behav. Brain Res. 2009, 200:192-196.
13. Bailey A., Le Couteur A., Gottesman I., Bolton P., Simonoff E., Yuzda E., Rutter M. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 1995, 25:63-77.
14. Belmonte M.K., Bourgeron T. Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat. Neurosci. 2006, 9:1221-1225.
15. Bessis A., Bechade C., Bernard D., Roumier A. Microglial control of neuronal death and synaptic properties. Glia 2007, 55:233-238.
16. Braunschweig D., Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., Van de Water J. Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 2008, 29:226-231.
17. Buxbaum J.D., Silverman J.M., Smith C.J., Greenberg D.A., Kilifarski M., Reichert J., Cook E.H., Fang Y., Song C.Y., Vitale R. Association between a GABRB3 polymorphism and autism. Mol. Psychiatry 2002, 7:311-316.
18. Cabanlit M., Wills S., Goines P., Ashwood P., Van de Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann. N. Y. Acad. Sci. 2007, 1107:92-103.
19. Cacci E., Claasen J.H., Kokaia Z. Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 2005, 80:789-797.
20. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R., Persico A.M., Levitt P. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. USA 2006, 103:16834-16839.
21. Careaga M., Van de Water J., Ashwood P. Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics 2010, 7:283-292.
22. Chen S.K., Tvrdik P., Peden E., Cho S., Wu S., Spangrude G., Capecchi M.R. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 2010, 141:775-785.
23. Chess S., Fernandez P., Korn S. Behavioral consequences of congenital rubella. J. Pediatr. 1978, 93:699-703.
24. Constantino J.N., Todd R.D. Genetic structure of reciprocal social behavior. Am. J. Psychiatry 2000, 157:2043-2045.
25. Corbett B.A., Kantor A.B., Schulman H., Walker W.L., Lit L., Ashwood P., Rocke D.M., Sharp F.R. A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol. Psychiatry 2007, 12:292-306.
26. Corriveau R.A., Huh G.S., Shatz C.J. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 1998, 21:505-520.
27. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr. Adolesc. Med. 2005, 159:151-157.
28. Croen L.A., Braunschweig D., Haapanen L., Yoshida C.K., Fireman B., Grether J.K., Kharrazi M., Hansen R.L., Ashwood P., Van de Water J. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol. Psychiatry 2008, 64:583-588.
29. Croonenberghs J., Wauters A., Devreese K., Verkerk R., Scharpe S., Bosmans E., Egyed B., Deboutte D., Maes M. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol. Med. 2002, 32:1457-1463.
30. Curran L.K., Newschaffer C.J., Lee L.C., Crawford S.O., Johnston M.V., Zimmerman A.W. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 2007, 120:e1386-e1392.
31. Daws M.R., Lanier L.L., Seaman W.E., Ryan J.C. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur. J. Immunol. 2001, 31:783-791.
32. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
33. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 2001, 7:1189-1193.
34. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., Kipnis J. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 2010, 207:1067-1080.
35. Derecki N.C., Quinnies K.M., Kipnis J. Alternatively activated myeloid (M2) cells enhance cognitive function in immune compromised mice. Brain Behav. Immun. 2011, 25:379-385.
36. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64:61-78.
37. Djukic M., Mildner A., Schmidt H., Czesnik D., Bruck W., Priller J., Nau R., Prinz M. Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 2006, 129:2394-2403.
38. Enstrom A., Krakowiak P., Onore C., Pessah I.N., Hertz-Picciotto I., Hansen R.L., Van de Water J.A., Ashwood P. Increased IgG4 levels in children with autism disorder. Brain Behav. Immun. 2009, 23:389-395.
39. Enstrom A.M., Lit L., Onore C.E., Gregg J.P., Hansen R.L., Pessah I.N., Hertz-Picciotto I., Van de Water J.A., Sharp F.R., Ashwood P. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav. Immun. 2009, 23:124-133.
40. Enstrom A.M., Van de Water J.A., Ashwood P. Autoimmunity in autism. Curr. Opin. Invest. Drugs 2009, 10:463-473.
41. Enstrom A.M., Onore C.E., Van de Water J.A., Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 2010, 24:64-71.
42. Evers M., Cunningham-Rundles C., Hollander E. Heat shock protein 90 antibodies in autism. Mol. Psychiatry 2002, 7(Suppl. 2):S26-S28.
43. Fairweather D., Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J. Autoimmun. 2009, 33:222-230.
44. Fukao T., Tanabe M., Terauchi Y., Ota T., Matsuda S., Asano T., Kadowaki T., Takeuchi T., Koyasu S. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 2002, 3:875-881.
45. Garbett K., Ebert P.J., Mitchell A., Lintas C., Manzi B., Mirnics K., Persico A.M. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 2008, 30:303-311.
46. Garden G.A., Moller T. Microglia biology in health and disease. J. Neuroimmune Pharmacol. 2006, 1:127-137.
47. Gasque P., Neal J.W., Singhrao S.K., McGreal E.P., Dean Y.D., Van B.J., Morgan B.P. Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities. Mol. Neurobiol. 2002, 25:1-17.
48. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
49. Goddard C.A., Butts D.A., Shatz C.J. Regulation of CNS synapses by neuronal MHC class I. Proc. Natl. Acad. Sci. USA 2007, 104:6828-6833.
50. Goines P., Haapanen L., Boyce R., Duncanson P., Braunschweig D., Delwiche L., Hansen R., Hertz-Picciotto I., Ashwood P., Van de Water J. Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav. Immun. 2011, 25:514-523.
51. Goshen I., Yirmiya R. Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 2009, 30:30-45.
52. Greer J.M., Capecchi M.R. Hoxb8 is required for normal grooming behavior in mice. Neuron 2002, 33:23-34.
53. Grigorenko E.L., Han S.S., Yrigollen C.M., Leng L., Mizue Y., Anderson G.M., Mulder E.J., de Bildt A., Minderaa R.B., Volkmar F.R., Chang J.T., Bucala R. Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 2008, 122:e438-e445.
54. Gruys E., Toussaint M.J., Niewold T.A., Koopmans S.J. Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. B 2005, 6:1045-1056.
55. Gupta S., Aggarwal S., Rashanravan B., Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J. Neuroimmunol. 1998, 85:106-109.
56. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
57. Harden L.M., du Plessis I., Poole S., Laburn H.P. Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats. Brain Behav. Immun. 2008, 22:838-849.
58. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflammation 2008, 5:15.
59. Heuer L., Ashwood P., Schauer J., Goines P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., Van de Water J. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res. 2008, 1:275-283.
60. Hryniewicz A., Bialuk I., Kaminski K.A., Winnicka M.M. Impairment of recognition memory in interleukin-6 knock-out mice. Eur. J. Pharmacol. 2007, 577:219-220.
61. Hsiao E.Y., Patterson P.H. Activation of the Maternal Immune System Induces Endocrine Changes in the Placenta via IL-6. Brain Behav. Immun 2011, 25:604-615.
62. Iwata Y., Tsuchiya K.J., Mikawa S., Nakamura K., Takai Y., Suda S., Sekine Y., Suzuki K., Kawai M., Sugihara G., Matsuzaki H., Hashimoto K., Tsujii M., Sugiyama T., Takei N., Mori N. Serum levels of P-selectin in men with high-functioning autism. Br. J. Psychiatry 2008, 193:338-339.
63. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
64. Jorde L.B., Hasstedt S.J., Ritvo E.R., Mason-Brothers A., Freeman B.J., Pingree C., McMahon W.M., Petersen B., Jenson W.R., Mo A. Complex segregation analysis of autism. Am. J. Hum. Genet. 1991, 49:932-938.
65. Kajizuka M., Miyachi T., Matsuzaki H., Iwata K., Shinmura C., Suzuki K., Suda S., Tsuchiya K.J., Matsumoto K., Iwata Y., Nakamura K., Tsujii M., Sugiyama T., Takei N., Mori N. Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:154-158.
66. Kates W.R., Burnette C.P., Eliez S., Strunge L.A., Kaplan D., Landa R., Reiss A.L., Pearlson G.D. Neuroanatomic variation in monozygotic twin pairs discordant for the narrow phenotype for autism. Am. J. Psychiatry 2004, 161:539-546.
67. Kim S.U., de Vellis J. Microglia in health and disease. J. Neurosci. Res. 2005, 81:302-313.
68. Korade Z., Mirnics K. Gene expression: the autism disconnect. Nature 2011, 474:294-295.
69. Lee J.Y., Huerta P.T., Zhang J., Kowal C., Bertini E., Volpe B.T., Diamond B. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat. Med. 2009, 15:91-96.
70. Lee L.C., Zachary A.A., Leffell M.S., Newschaffer C.J., Matteson K.J., Tyler J.D., Zimmerman A.W. HLA-DR4 in families with autism. Pediatr. Neurol. 2006, 35:303-307.
71. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 207:111-116.
72. Mandal M., Marzouk A.C., Donnelly R., Ponzio N.M. Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav. Immun. 2011, 25:863-871.
73. Martin L.A., Ashwood P., Braunschweig D., Cabanlit M., Van de Water J., Amaral D.G. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 2008, 22:806-816.
74. McAllister A.K., van de Water J. Breaking boundaries in neural-immune interactions. Neuron 2009, 64:9-12.
75. Prevalence of autism spectrum disorders - autism, developmental disabilities monitoring network, United States. MMWR Surveill. Summ. 2009, 58:1-20. MMWR.
76. Moessner R., Marshall C.R., Sutcliffe J.S., Skaug J., Pinto D., Vincent J., Zwaigenbaum L., Fernandez B., Roberts W., Szatmari P., Scherer S.W. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 2007, 81:1289-1297.
77. Monteleone I., Monteleone G., Fina D., Caruso R., Petruzziello C., Calabrese E., Biancone L., Pallone F. A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis. Gastroenterology 2006, 130:389-397.
78. Moore A.H., Wu M., Shaftel S.S., Graham K.A., O'Banion M.K. Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memory. Neuroscience 2009, 164:1484-1495.
79. Morgan J.T., Chana G., Pardo C.A., Achim C., Semendeferi K., Buckwalter J., Courchesne E., Everall I.P. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 2010, 68:368-376.
80. Nagarajan R.P., Patzel K.A., Martin M., Yasui D.H., Swanberg S.E., Hertz-Picciotto I., Hansen R.L., Van de Water J., Pessah I.N., Jiang R., Robinson W.P., LaSalle J.M. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res. 2008, 1:169-178.
81. Neefjes J.J., Momburg F. Cell biology of antigen presentation. Curr. Opin. Immunol. 1993, 5:27-34.
82. Odell D., Maciulis A., Cutler A., Warren L., McMahon W.M., Coon H., Stubbs G., Henley K., Torres A. Confirmation of the association of the C4B null allelle in autism. Hum. Immunol. 2005, 66:140-145.
83. Okada K., Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., Sekine Y., Suda S., Suzuki K., Sugihara G., Matsuzaki H., Sugiyama T., Kawai M., Minabe Y., Takei N., Mori N. Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:187-190.
84. Onore C., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R., Van de Water J., Ashwood P. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J. Neuroimmunol. 2009, 216:126-134.
85. Opp M.R., Krueger J.M. Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever. Am J Physiol 1991, 260:R453-457.
86. Paloneva J., Autti T., Raininko R., Partanen J., Salonen O., Puranen M., Hakola P., Haltia M. CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology 2001, 56:1552-1558.
87. Paribello C., Tao L., Folino A., Berry-Kravis E., Tranfaglia M., Ethell I.M., Ethell D.W. Open-label add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol. 2010, 10:91.
88. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 2009, 204:313-321.
89. Plioplys A.V. Intravenous immunoglobulin treatment of children with autism. J Child Neurol 1998, 13:79-82.
90. Samuelsson A.M., Jennische E., Hansson H.A., Holmang A. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1345-1356.
91. Sandler R.H., Finegold S.M., Bolte E.R., Buchanan C.P., Maxwell A.P., Vaisanen M.L., Nelson M.N., Wexler H.M. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000, 15:429-435.
92. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., Besedovsky H.O. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci USA 1998, 95:7778-7783.
93. Scifo R., Cioni M., Nicolosi A., Batticane N., Tirolo C., Testa N., Quattropani M.C., Morale M.C., Gallo F., Marchetti B. Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Ann Ist Super Sanita 1996, 32:351-359.
94. Shatz C.J. MHC class I: an unexpected role in neuronal plasticity. Neuron 2009, 64:40-45.
95. Shenoy S., Arnold S., Chatila T. Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome. J Pediatr 2000, 136:682-687.
96. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460:753-757.
97. Silva S.C., Correia C., Fesel C., Barreto M., Coutinho A.M., Marques C., Miguel T.S., Ataide A., Bento C., Borges L., Oliveira G., Vicente A.M. Autoantibody repertoires to brain tissue in autism nuclear families. J. Neuroimmunol. 2004, 152:176-182.
98. Singer H.S., Morris C.M., Williams P.N., Yoon D.Y., Hong J.J., Zimmerman A.W. Antibrain antibodies in children with autism and their unaffected siblings. J. Neuroimmunol. 2006, 178:149-155.
99. Singer H.S., Morris C., Gause C., Pollard M., Zimmerman A.W., Pletnikov M. Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model. J. Neuroimmunol. 2009, 211:39-48.
100. Singh V.K., Warren R.P., Odell J.D., Warren W.L., Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 1993, 7:97-103.
101. Singh V.K., Singh E.A., Warren R.P. Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biol. Psychiatry 1997, 41:753-755.
102. Singh V.K., Warren R., Averett R., Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 1997, 17:88-90.
103. Skaar D.A., Shao Y., Haines J.L., Stenger J.E., Jaworski J., Martin E.R., DeLong G.R., Moore J.H., McCauley J.L., Sutcliffe J.S., Ashley-Koch A.E., Cuccaro M.L., Folstein S.E., Gilbert J.R., Pericak-Vance M.A. Analysis of the RELN gene as a genetic risk factor for autism. Mol. Psychiatry 2005, 10:563-571.
104. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27:10695-10702.
105. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Borglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Bottcher Y., Olesen J., Breuer R., Moller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Rethelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
106. Steffenburg S., Gillberg C., Hellgren L., Andersson L., Gillberg I.C., Jakobsson G., Bohman M. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J. Child Psychol. Psychiatry 1989, 30:405-416.
107. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059.
108. Steup-Beekman G., Steens S., van Buchem M., Huizinga T. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives. Lupus 2007, 16:329-334.
109. Stubbs E.G., Crawford M.L. Depressed lymphocyte responsiveness in autistic children. J. Autism Child Schizophr. 1977, 7:49-55.
110. Sweeten T.L., Posey D.J., McDougle C.J. High blood monocyte counts and neopterin levels in children with autistic disorder. Am. J. Psychiatry 2003, 160:1691-1693.
111. Swisher C.N., Swisher L. Letter: congenital rubella and autistic behavior. N. Engl. J. Med. 1975, 293:198.
112. Takahashi K., Rochford C.D., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 2005, 201:647-657.
113. Todd R.D., Hickok J.M., Anderson G.M., Cohen D.J. Antibrain antibodies in infantile autism. Biol. Psychiatry 1988, 23:644-647.
114. Torrente F., Ashwood P., Day R., Machado N., Furlano R.I., Anthony A., Davies S.E., Wakefield A.J., Thomson M.A., Walker-Smith J.A., Murch S.H. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol. Psychiatry 2002, 7:375-382. 334.
115. Torrente F., Anthony A., Heuschkel R.B., Thomson M.A., Ashwood P., Murch S.H. Focal-enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacter pylori gastritis. Am. J. Gastroenterol. 2004, 99:598-605.
116. Torres A.R., Maciulis A., Odell D. The association of MHC genes with autism. Front Biosci. 2001, 6:D936-943.
117. Torres A.R., Maciulis A., Stubbs E.G., Cutler A., Odell D. The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum. Immunol. 2002, 63:311-316.
118. Torres A.R., Sweeten T.L., Cutler A., Bedke B.J., Fillmore M., Stubbs E.G., Odell D. The association and linkage of the HLA-A2 class I allele with autism. Hum. Immunol. 2006, 67:346-351.
119. Tsuchiya K.J., Hashimoto K., Iwata Y., Tsujii M., Sekine Y., Sugihara G., Matsuzaki H., Suda S., Kawai M., Nakamura K., Minabe Y., Yagi A., Iyo M., Takei N., Mori N. Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Biol. Psychiatry 2007, 62:1056-1058.
120. Ulvestad E., Williams K., Matre R., Nyland H., Olivier A., Antel J. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J. Neuropathol. Exp. Neurol. 1994, 53:27-36.
121. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57:67-81.
122. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
123. Vojdani A., Campbell A.W., Anyanwu E., Kashanian A., Bock K., Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J. Neuroimmunol. 2002, 129:168-177.
124. Vojdani A., Mumper E., Granpeesheh D., Mielke L., Traver D., Bock K., Hirani K., Neubrander J., Woeller K.N., O'Hara N., Usman A., Schneider C., Hebroni F., Berookhim J., McCandless J. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J. Neuroimmunol. 2008, 205:148-154.
125. Warren R.P., Foster A., Margaretten N.C. Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psychiatry 1987, 26:333-335.
126. Widera D., Mikenberg I., Elvers M., Kaltschmidt C., Kaltschmidt B. Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling. BMC Neurosci. 2006, 7:64.
127. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D.G., Van de Water J. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav. Immun. 2009, 23:64-74.
128. Wills S., Rossi C.C., Bennett J., Martinez-Cerdeno V., Ashwood P., Amaral D.G., Van de Water J. Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Mol. Autism 2011, 2:5.
129. Wiznitzer M. Autism and tuberous sclerosis. J. Child Neurol. 2004, 19:675-679.
130. Wu S., Jia M., Ruan Y., Liu J., Guo Y., Shuang M., Gong X., Zhang Y., Yang X., Zhang D. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol. Psychiatry 2005, 58:74-77.
131. Zalcman S.S. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Res. 2002, 944:157-164.
132. Zerbo O., Iosif A.M., Delwiche L., Walker C., Hertz-Picciotto I. Month of conception and risk of autism. Epidemiology. 2011, 22:469-475.
133. Ziv Y., Schwartz M. Immune-based regulation of adult neurogenesis: implications for learning and memory. Brain Behav. Immun. 2008, 22:167-176.
134. Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., Cohen H., Kipnis J., Schwartz M. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 2006, 9:268-275.